SLC7A5 and breast cancer: Importantly, a study revealed the relation between SLC7A5 overexpression and tamoxifen resistance in breast cancer cells, and silencing SLC7A5 expression was sufficient to increase the sensitivity of cancer cells to tamoxifen.